HOME › DRUGS › OXIGLUTATIONE
ACTIVE SUBSTANCE / INN

OXIGLUTATIONE

Brand name(s): NAVSTEL
FDA LISTED
DISCONTINUED
NDA022193
ACTIVE SUBSTANCE
Oxiglutatione
REGULATORS
FDA
SPONSORS / MAH
ALCON PHARMS LTD
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NAVSTELNDA022193ALCON PHARMS LTDDiscontinued

FULL INTELLIGENCE ON OXIGLUTATIONE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →